Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × polatuzumab vedotin × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 25 Lymphoma, Non-Hodgkin 7 Lymphoma, B-Cell 5 Lymphoma 4 Recurrence 3 Lymphoma, Follicular 3 Leukemia, Lymphocytic, Chronic, B-Cell 2 Dendritic Cell Sarcoma, Interdigitating 2 Neoplasms 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Hairy Cell 1 Hodgkin Disease 1 Burkitt Lymphoma 1

Interventions

Rituximab 47 Cyclophosphamide 38 ibrutinib 22 fludarabine 22 acalabrutinib 20 venetoclax 18 Bendamustine Hydrochloride 18 zanubrutinib 15 Lenalidomide 15 CT-P10 13 fludarabine phosphate 12 Cytarabine 12 pirtobrutinib 11 obinutuzumab 11 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Etoposide 9 Vincristine 8 Doxorubicin 8 Biopsy 8 glofitamab 7 Whole-Body Irradiation 7 Mycophenolic Acid 6 Methotrexate 6 Melphalan 6 Peripheral Blood Stem Cell Transplantation 5 Immunotherapy, Adoptive 5 Cyclosporine 5 orelabrutinib 4 brexucabtagene autoleucel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡